Impact of treatment line on outcomes with salvage ipilimumab plus nivolumab in metastatic renal cell carcinoma (mRCC) Meeting Abstract


Authors: Kotecha, R.; Lee, C. H.; Knezevic, A.; Shah, N. J.; Carlo, M. I.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
Abstract Title: Impact of treatment line on outcomes with salvage ipilimumab plus nivolumab in metastatic renal cell carcinoma (mRCC)
Meeting Title: 56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 15 Suppl.
Meeting Dates: 2020 May 29-31
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-05-20
Language: English
ACCESSION: WOS:000560368306244
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.15_suppl.e17092
Notes: Meeting Abstract: e17092 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sujata Patil
    511 Patil
  2. Robert Motzer
    1243 Motzer
  3. Darren Richard Feldman
    340 Feldman
  4. Martin Henner Voss
    288 Voss
  5. Maria Isabel Carlo
    162 Carlo
  6. Chung-Han   Lee
    157 Lee
  7. Andrea Knezevic
    106 Knezevic
  8. Ritesh Rajesh Kotecha
    91 Kotecha
  9. Neil Jayendra Shah
    83 Shah